Patents by Inventor Denis Riendeau

Denis Riendeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Whole cell assay for cathepsin K activity
    Patent number: 6346373
    Abstract: The present invention relates to a whole cell assay for cathepsin K. The present invention is useful for determining cathepsin K activity in a mammalian cell systems and for identifying and evaluating inhibitors of cathepsin K.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: February 12, 2002
    Assignee: Merck Frosst Canada & Co.,
    Inventors: Joseph Mancini, Denis Riendeau, David Claveau
  • Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
    Publication number: 20020016342
    Abstract: The present invention provides a method for the treatment or prophylaxis of COX-2-mediated conditions in patients who are at risk of developing thromboembolic events which comprises administering to said patient a therapeutically or prophylactically effective amount of a COX-2 selective inhibitor and a cardiovascular protective amount of a thromboxane inhibitor, as well as compositions therefor.
    Type: Application
    Filed: May 14, 2001
    Publication date: February 7, 2002
    Inventors: Edward Scolnick, Kathleen Metters, Denis Riendeau, Mervyn Turner